Adults 9 to 11, any sex, with Hypercholesterolemia or Hypercholesterolemia, Familial. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Lipid Panel OrderPrimary· 1 day
Provider ordered a lipid panel to an eligible patient during the patient's first visit within the study period (binary variable).
Group
Value
95% CI
Passive Control
156
Best Practice Alert (BPA-only)
454
Health Maintenance Topic (HMT-only)
236
BPA+HMT
494
Lipid Panel ScreeningPrimary· 1 week
Patient completed a lipid panel screening within seven days of the patient's first visit (binary variable). This screening is not linked to any order made at the patient's first visit (i.e., Outcome Measure 1).
Group
Value
95% CI
Passive Control
47
Best Practice Alert (BPA-only)
98
Health Maintenance Topic (HMT-only)
70
BPA+HMT
120
Sponsor's own description
The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-universal guidelines. This will help quantify the relative effectiveness of different alerts and combinations of alerts on provider prescribing behavior and patient uptake of screening.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT04903717 — Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
· NA
· completed
Other recruiting trials for Hypercholesterolemia
Currently open trials in the same condition.
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors
· NA
· recruiting
NCT07374861 — Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
· recruiting
NCT07295327 — Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia
· NA
· recruiting
NCT06568601 — Pharmacogenomic Informed Statin Prescribing
· NA
· recruiting
NCT06423365 — A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
· NA
· active not recruiting
Other Geisinger Clinic trials
Trials by the same sponsor.
NCT07197801 — Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso
· NA
· recruiting
NCT06936709 — Perioperative Colchicine for TKA
· Phase 4
· not yet recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation
· NA
· recruiting
NCT07028398 — CMSL Ambulatory Sensitive Condition Nudge Study 2
· NA
· recruiting
NCT06696066 — PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder
· NA
· completed
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Geisinger Clinic
Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04118348.